• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. SENSAR; MONOFOCAL IOLS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. SENSAR; MONOFOCAL IOLS Back to Search Results
Model Number AR40E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Edema (1820); Blurred Vision (2137); Burning Sensation (2146)
Event Date 08/27/2019
Event Type  Injury  
Manufacturer Narrative
Date of event: unknown, information not provided.Catalog#: unknown, as the serial number was not provided.Expiration date: unknown, as the serial number was not provided.Serial#: unknown, not provided.Unique identifier: unknown, as the serial number was not provided.Explant date: not applicable, there is no indication the lens has been explanted.Device manufacture date: unknown, as the serial# was not provided.(b)(4).Device evaluation: the product testing could not be performed as the product was not returned.The reported complaint could not be verified.Manufacturing record review: the manufacturing records for the product were reviewed.The product was manufactured and released according to specifications.A search revealed that no similar complaints were received for this production order.Conclusion: as a result of the investigation there is no indication of a product quality deficiency and the reported issue could not be verified.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event Description
It was reported that a model ar40e intraocular lens (iol) was implanted into the patient's left eye.Additionally, a piggy back lens is also implanted.The doctor reported that their patient experienced unexpected post-op refraction.During their post-op checkup, the patient's mr (manifest refraction) was -19.0 20/800 not clear.Reported symptoms are pseudophakia, myopia, astigmatism, blurry vision, and burning sensation.The doctor also reported edema peripherally.The eye lid was normal, and the pupil was irregular and sluggish.No relative afferent pupillary defect (rapd) noted.Both iols were in a good position.Reportedly the patient had no discomfort and his visual acuity slightly improved.The patient was prescribed gatifloxacin and prednisolone.No further information was provided.
 
Manufacturer Narrative
This correction mdr is being submitted to address inaccurate information in section f on the xml version of the previous submission caused by a software glitch in the transmission process.The internal non-conformance numbers for this software issue are nr-0148919 and capa-010215.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENSAR
Type of Device
MONOFOCAL IOLS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
1700 e st andrew place
santa ana CA 92705
MDR Report Key9114516
MDR Text Key160911818
Report Number2648035-2019-01037
Device Sequence Number1
Product Code HQL
UDI-Public(01)
Combination Product (y/n)Y
PMA/PMN Number
P980040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/01/2005,11/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAR40E
Device Catalogue NumberAR40E
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received10/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age30 YR
-
-